These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 19854625)

  • 21. Serotonin receptor 1A-1019C/G variant: impact on antidepressant pharmacoresponse in melancholic depression?
    Baune BT; Hohoff C; Roehrs T; Deckert J; Arolt V; Domschke K
    Neurosci Lett; 2008 May; 436(2):111-5. PubMed ID: 18387740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does neuropeptide Y (NPY) mediate the effects of psychotropic drugs?
    Obuchowicz E; Krysiak R; Herman ZS
    Neurosci Biobehav Rev; 2004 Oct; 28(6):595-610. PubMed ID: 15527865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leu7Pro polymorphism in the neuropeptide Y (NPY) gene is associated with impaired glucose tolerance and type 2 diabetes in Swedish men.
    Nordman S; Ding B; Ostenson CG; Kärvestedt L; Brismar K; Efendic S; Gu HF
    Exp Clin Endocrinol Diabetes; 2005 May; 113(5):282-7. PubMed ID: 15926114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic variants in the angiotensin I-converting-enzyme (ACE) and angiotensin II receptor (AT1) gene and clinical outcome in depression.
    Bondy B; Baghai TC; Zill P; Schule C; Eser D; Deiml T; Zwanzger P; Ella R; Rupprecht R
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):1094-9. PubMed ID: 15949885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic association analysis of functional polymorphisms in neuronal nitric oxide synthase 1 gene (NOS1) and mood disorders and fluvoxamine response in major depressive disorder in the Japanese population.
    Okumura T; Kishi T; Okochi T; Ikeda M; Kitajima T; Yamanouchi Y; Kinoshita Y; Kawashima K; Tsunoka T; Inada T; Ozaki N; Iwata N
    Neuropsychobiology; 2010; 61(2):57-63. PubMed ID: 20016223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cortico-limbic response to personally challenging emotional stimuli after complete recovery from depression.
    Hooley JM; Gruber SA; Parker HA; Guillaumot J; Rogowska J; Yurgelun-Todd DA
    Psychiatry Res; 2009 Feb; 171(2):106-19. PubMed ID: 19176279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinical application of ABCB1 genotyping in antidepressant treatment: a pilot study.
    Breitenstein B; Scheuer S; Pfister H; Uhr M; Lucae S; Holsboer F; Ising M; Brückl TM
    CNS Spectr; 2014 Apr; 19(2):165-75. PubMed ID: 23880209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. No influence of PTGS2 polymorphisms on response and remission to antidepressants in major depression.
    Serretti A; Chiesa A; Calati R; Massat I; Linotte S; Kasper S; Lecrubier Y; Fink M; Antonijevic I; Forray C; Snyder L; Bollen J; Zohar J; De Ronchi D; Souery D; Mendlewicz J
    Psychiatry Res; 2011 Jun; 188(1):166-9. PubMed ID: 21168919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The BDNF Val66Met polymorphism affects amygdala activity in response to emotional stimuli: evidence from a genetic imaging study.
    Montag C; Reuter M; Newport B; Elger C; Weber B
    Neuroimage; 2008 Oct; 42(4):1554-9. PubMed ID: 18603005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuropeptide Y gene polymorphism and plasma neuropeptide Y level in febrile seizure patients in Taiwan.
    Lin LC; Lin HS; Yang RC
    Kaohsiung J Med Sci; 2007 Nov; 23(11):560-5. PubMed ID: 18055304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Effects of Antidepressants on Neuropeptide Y in Patients with Depression and Anxiety.
    Ozsoy S; Olguner Eker O; Abdulrezzak U
    Pharmacopsychiatry; 2016 Jan; 49(1):26-31. PubMed ID: 26789271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Levetiracetam prevents changes in levels of brain-derived neurotrophic factor and neuropeptide Y mRNA and of Y1- and Y5-like receptors in the hippocampus of rats undergoing amygdala kindling: implications for antiepileptogenic and mood-stabilizing properties.
    Husum H; Bolwig TG; Sánchez C; Mathé AA; Hansen SL
    Epilepsy Behav; 2004 Apr; 5(2):204-15. PubMed ID: 15123022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. No interactions between genetic polymorphisms and stressful life events on outcome of antidepressant treatment.
    Bukh JD; Bock C; Vinberg M; Werge T; Gether U; Kessing LV
    Eur Neuropsychopharmacol; 2010 May; 20(5):327-35. PubMed ID: 20022223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacogenomics of antidepressant drugs.
    Horstmann S; Binder EB
    Pharmacol Ther; 2009 Oct; 124(1):57-73. PubMed ID: 19563827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association study of p11 gene with major depressive disorder, suicidal behaviors and treatment response.
    Tzang RF; Hong CJ; Liou YJ; Yu YW; Chen TJ; Tsai SJ
    Neurosci Lett; 2008 Dec; 447(1):92-5. PubMed ID: 18838110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The angiotensin I converting enzyme insertion/deletion polymorphism influences therapeutic outcome in major depressed women, but not in men.
    Baghai TC; Schule C; Zill P; Deiml T; Eser D; Zwanzger P; Ella R; Rupprecht R; Bondy B
    Neurosci Lett; 2004 Jun; 363(1):38-42. PubMed ID: 15157992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variation in the genes encoding vesicular monoamine transporter 2 and beta-1 adrenergic receptor and antidepressant treatment outcome.
    Crowley JJ; Lipsky RH; Lucki I; Berrettini WH
    Psychiatr Genet; 2008 Oct; 18(5):248-51. PubMed ID: 18797399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of the tryptophan hydroxylase 1 gene A218C polymorphism on amygdala activity in response to affective facial stimuli in patients with major depressive disorder.
    Lee BT; Lee HY; Lee BC; Pae CU; Yoon BJ; Ryu SG; Choi IG; Lee MS; Ham BJ
    Genes Brain Behav; 2009 Jul; 8(5):512-8. PubMed ID: 19500158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TPH2 gene variants and anxiety during alcohol detoxification outcome.
    Serretti A; Liappas I; Mandelli L; Albani D; Forloni G; Malitas P; Piperi C; Politis A; Tzavellas EO; Papadopoulou-Daifoti Z; Zisaki A; Prato F; Batelli S; Polito L; De Ronchi D; Kalofoutis A
    Psychiatry Res; 2009 May; 167(1-2):106-14. PubMed ID: 19361870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The BDNF Val66Met polymorphism impacts parahippocampal and amygdala volume in healthy humans: incremental support for a genetic risk factor for depression.
    Montag C; Weber B; Fliessbach K; Elger C; Reuter M
    Psychol Med; 2009 Nov; 39(11):1831-9. PubMed ID: 19335934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.